 Methicillin-resistant Staphylococcus aureus pyruvate kinase (MRSA PK) recently identified target development novel antibacterial agents. Testing series 1,2-bis(3-indolyl)ethanes MRSA PK led discovery potent inhibitor selective human isoforms.